John J. McCabe, Chief Financial Officer at Eleven Biotherapeutics, Inc. (EBIO), sold 1,170 shares at $4.80 ($6K) on 2016-08-15, disclosed to the SEC on 2016-08-17.
Open-market sale of $6k EBIO by Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |